Systemic factors may not be predictive of VA outcomes for diabetic patients after cataract surgery
October 26th 2022A team of investigators evaluated VA outcomes after cataract surgery and the factors associated with good visual outcomes in a population of patients diagnosed with type 2 diabetes.
Read More
Genentech recalling ranibizumab injection ocular implant in US
October 17th 2022The company noted that testing of a commercial supply of the implants, which included exposing them to multiple punctures with a needle, found they did not meet their standards. The company has notified the FDA, and is working with the agency on the recall process.
Read More
Study: VKC treatment proves inadequate, costly for symptom/complication control
October 8th 2022According to investigators, treatment options available for patients diagnosed with vernal keratoconjunctivitis are less than adequate and these patients have higher rates of corneal complications and use more healthcare resources despite treatment.
Read More
AAO LIVE: Researchers target risk factors for development of rhegmatogenous retinal detachments
October 3rd 2022In a presentation at the American Academy of Ophthalmology’s 2022 annual meeting in Chicago, William Kearney and Dan Gong, MD, discussed how patients with a unilateral retinal detachment frequently ask about the risk of developing an RRD in their fellow eye.
Read More
In a presentation at the American Academy of Ophthalmology’s 2022 annual meeting in Chicago, Ines Lains, MD, PhD, detailed how adjunct treatment with intravitreal antivirals or early pars plana vitrectomy did not improve the rates of retinal detachment in patients diagnosed with acute retinal necrosis.
Read More